Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
Top Cited Papers
- 1 May 2015
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 67 (5), 825-836
- https://doi.org/10.1016/j.eururo.2014.07.010
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Intermittent Androgen Suppression for Rising PSA Level after RadiotherapyThe New England Journal of Medicine, 2012
- Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapyBMC Cancer, 2012
- A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapyBJU International, 2011
- Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate CancerJournal of Urology, 2010
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate CancerJournal of Urology, 2010
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular RiskCirculation, 2010
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate CancerJNCI Journal of the National Cancer Institute, 2009
- Lack of an Effect of High Dose Isoflavones in Men With Prostate Cancer Undergoing Androgen Deprivation TherapyJournal of Urology, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerThe New England Journal of Medicine, 2009
- A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)Annals of Oncology, 2009